The anxiolytics market is expected to witness significant growth during the forecast period. Emerging markets and huge investment in research and development are the factors responsible for the growth of this market. The growth of anxiolytics market enhanced by the growing cases of mental illness and rise in the research and development activities which many pharmaceuticals’ companies conduct. COVID-19 also had a major impact on the market growth.
Frequently Asked Questions
Increasing Demand for Novel Therapies and Rising Demand for Oral Drugs
The primary challenges include Lack of skilled professionals and High Cost
U.S. is expected to dominate the global busway market, The U.S. has a high prevalence of anxiety disorders, including generalized anxiety disorder (GAD), panic disorder, and social anxiety disorder. With mental health issues being a significant concern in the country, the demand for anxiolytic medications is strong.
Asia-Pacific dominates the market due to the developing healthcare facilities, large number of generic manufacturer and rise in government initiatives and specialist communities.
India is expected to witness the highest CAGR in the busway market. There has been a significant rise in the awareness and recognition of mental health issues, including anxiety disorders, in India. As more people become aware of mental health conditions, there is growing acceptance of treatment options like anxiolytics.
